Inotiv, Inc. Public Market Comparables
Find the most relevant public market comparables for Inotiv, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Inotiv, Inc. is a leading contract research organization (CRO) providing nonclinical and analytical drug discovery and development services, research models, and related products and services. The company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians, primarily for small molecule drug candidates, biotherapeutics, and biomedical devices. They also sell research-quality animals and diets to pharmaceutical and medical device industries, academia, and government clients.
Business Model
Contract Research Organization (CRO) offering services across the drug development lifecycle, including discovery, preclinical testing, and analytical services. They also provide research models (live animals), lab animal diets, bedding, and support services.
Target Customers
Pharmaceutical and medical device companies, biotechnology companies, academia, and government clients.
Specific Focus
Nonclinical and analytical drug discovery and development services, research models and related products and services for pharmaceutical, medical device, and biotechnology companies.
Location
West Lafayette, Indiana
CEO
Robert Leasure Jr.
Industry
Life sciences
Sub Sector
Contract Research Organizations (CROs)
3yr Revenue Growth
847%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Inotiv, Inc. in the Pharmaceutical industry sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Inotiv, Inc.? Our platform provides detailed analysis of Inotiv, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Inotiv, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Inotiv, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceutical industry sector, Inotiv, Inc. operates in the specialized Contract Research Organizations (CROs) sub-sector. Understanding how Inotiv, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Contract Research Organizations (CROs) space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Corellium
Technology • Software & services
Corellium develops security research software for ARM device virtualization used for mobile security research, mobile app testing, and IoT device modeling. Their software provides native performance, cloud convenience, and advanced development tools for phones and devices, enabling scalable, efficient, and innovative development of ARM-based device ecosystems.
Curi Bio
Life Sciences • Life sciences
Curi Bio is a biotechnology company focused on developing human-relevant platforms for drug discovery and development. The company offers advanced 3D tissue models of disease, biosystems for clinically relevant functional analyses, and AI/ML-enabled insights to inform R&D decision-making in drug safety, efficacy, and potency. Curi Bio's products and services are designed to build mature and predictive human iPSC-derived tissues, with a focus on cardiac, musculoskeletal, and neuromuscular models, supporting the preclinical drug development process.
Aclaris Therapeutics Inc.
Biotechnology • Life sciences
Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics (identifying and developing therapies for immuno-inflammatory diseases) and contract research (providing laboratory services). A majority of its revenue comes from the therapeutics segment.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Inotiv, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free